Clinical trial
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a Proof of Concept Study
NCT03489044 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a Proof of Concept Study
- Lead sponsor
- University of Oxford
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 28, 2018
- Completion date
- March 21, 2022
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.